UK Launches National Allergy Strategy to Improve Allergy Care

Overview

The UK has introduced its first National Allergy Strategy to tackle fragmented allergy services and rising demand, affecting one in three people. The strategy outlines a coordinated four-nation plan to enhance prevention, diagnosis, treatment, and management of allergic diseases.

Background

Allergic diseases have become increasingly prevalent in the UK, with rates among the highest globally. Allergic rhinitis and eczema prevalence has tripled since the 1970s, and hospital admissions for anaphylaxis have tripled between 1998 and 2018. Allergy accounts for approximately 6% of all GP visits and 10% of GP prescribing budgets. Current challenges include inconsistent care pathways, limited specialist capacity, and gaps in data and surveillance.

Data Highlights

Key Findings

• The National Allergy Strategy is the UK’s first coordinated plan addressing allergy prevention, diagnosis, treatment, and management across all four nations.
• One in three people in the UK are affected by allergic diseases, with allergy-related GP visits and prescribing consuming significant healthcare resources.
• There is a critical shortage of immunology specialists, with 75% of services understaffed to meet clinical demand.
• Key priorities include reducing preventable harm, improving quality of life, addressing health inequalities, and standardizing care across regions.
• The strategy extends beyond healthcare to sectors such as education, catering, retail, and transport to improve allergy safety in daily environments.
• Recommendations include mandatory allergy training in schools, improved access to essential medicines, a national allergy register, and integration of allergy care into workforce planning and professional education.

Clinical Implications

Clinicians should anticipate increased integration of allergy services within primary and community care, supported by enhanced specialist workforce capacity. Improved training and standardized care pathways will facilitate earlier diagnosis and better management, potentially reducing severe allergic reactions and hospital admissions. Awareness of the strategy’s cross-sector approach can help healthcare professionals collaborate with schools and other public services to improve patient safety.

Conclusion

The UK’s National Allergy Strategy represents a comprehensive effort to address the growing burden of allergic diseases through coordinated system reforms, workforce development, and cross-sector collaboration. Successful implementation promises improved patient outcomes and more sustainable allergy care.

References

1. Allergy UK/National Allergy Strategy Group 2024 -- UK Launches National Allergy Strategy